Vesper Ventures

Symbiomics specializes in developing next-generation biologicals using robust-colonizing microbes for enhancing plant growth. They employ sequencing technologies, machine learning, and genome editing tools to create innovative products that improve agricultural performance sustainably.

HapiSeeds is a technology company focused on sustainable agriculture. It develops innovative solutions to increase food production while minimizing environmental impact. The company's core business involves creating new commercial plant varieties through advanced plant engineering techniques, such as genome editing, and providing molecular tools to assist breeders and farmers. These technologies aim to enhance plant productivity, reduce the need for chemical fertilizers and irrigation, and improve disease resistance, ultimately promoting more efficient and sustainable agricultural practices.

Cellertz Bio is a biotechnology research company focused on advancing cell therapies for cancer and other diseases. The company employs an integrated in silico and experimental approach to identify and control specific gene regulatory networks that influence cell behaviors. By determining which genes to modulate, Cellertz Bio aims to enhance the effectiveness of cell therapies and contribute to advancements in the healthcare sector. Their innovative methods seek to improve treatment outcomes and provide new solutions in the fight against complex diseases.

Symbiomics specializes in developing next-generation biologicals using robust-colonizing microbes for enhancing plant growth. They employ sequencing technologies, machine learning, and genome editing tools to create innovative products that improve agricultural performance sustainably.

Symbiomics specializes in developing next-generation biologicals using robust-colonizing microbes for enhancing plant growth. They employ sequencing technologies, machine learning, and genome editing tools to create innovative products that improve agricultural performance sustainably.

Inedita Bio is a biotechnology company focused on sustainable food production through its innovative plant genome editing platform. The company develops non-transgenic, genome-edited crop varieties that enhance resistance to pests and diseases while improving water and nutrient use efficiency. By making precise modifications to the genetic code of plants, Inedita Bio aims to recover lost variability caused by traditional breeding methods. This approach not only aims to optimize crop performance but also significantly reduces reliance on chemical pesticides in agriculture, promoting a more sustainable food production system.

Vyro Bio is a biotechnology company focused on developing cancer-killing viruses targeting adult and pediatric central nervous system tumors. Its innovative approach leverages the oncolytic properties of the Zika Virus.

FUTR BIO is a biotechnology company dedicated to preventing and treating diseases like infections and cancer. It specializes in developing mRNA vaccine technologies, aiming to induce robust immune responses by precisely controlling the mammalian immune system.

Aptah Biosciences is a biotechnology company specializing in drug discovery. It uses a proprietary algorithm to streamline the drug development process, reducing time, costs, and risks associated with lead optimization and customization. Aptah's platform has successfully developed new molecules for cancer treatment, anti-inflammatory drugs, and gene therapy oligonucleotides. Its current focus is on developing an RNA therapy to target age-related diseases, with potential applications in neurodegenerative disorders and cancer, areas of significant unmet medical need and commercial potential.